$496 Million is the total value of Progeny 3, Inc.'s 23 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
STERLING CHECK CORP | $52,396,000 | -38.3% | 3,212,512 | 0.0% | 10.56% | -33.8% | ||
IEFA | ISHARES TRcore msci eafe | $14,995,000 | -15.3% | 254,792 | 0.0% | 3.02% | -9.1% | |
SPINDLETOP HEALTH ACQUISITIO | $14,955,000 | +0.1% | 1,500,000 | 0.0% | 3.01% | +7.5% | ||
LMBS | FIRST TR EXCHANGE-TRADED FDfst low oppt eft | $7,516,000 | -1.3% | 155,615 | 0.0% | 1.51% | +5.9% | |
DNMR | DANIMER SCIENTIFIC INC | $2,379,000 | -22.2% | 521,757 | 0.0% | 0.48% | -16.6% | |
NXE | NEXGEN ENERGY LTD | $1,740,000 | -36.6% | 484,718 | 0.0% | 0.35% | -31.8% | |
SPINDLETOP HEALTH ACQUISITIO*w exp 99/99/999 | $60,000 | -46.9% | 750,000 | 0.0% | 0.01% | -42.9% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-15
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 25 | Q3 2023 | 24.8% |
ISHARES TR | 24 | Q4 2019 | 21.5% |
VANECK VECTORS ETF TR | 23 | Q1 2022 | 6.8% |
CAMECO CORP | 21 | Q3 2023 | 12.3% |
ISHARES INC | 19 | Q3 2018 | 22.4% |
TPG SPECIALTY LENDING INV | 19 | Q1 2020 | 18.4% |
ALPS ETF TR | 19 | Q4 2019 | 4.6% |
WISDOMTREE TR | 18 | Q1 2020 | 37.5% |
ENTERPRISE PRODS PARTNERS L | 18 | Q3 2023 | 16.3% |
ISHARES INC | 17 | Q1 2018 | 10.9% |
View Progeny 3, Inc.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-15 |
13F-HR | 2024-02-14 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-15 |
13F-HR | 2023-02-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-15 |
13F-HR | 2022-05-16 |
SC 13G | 2022-02-17 |
View Progeny 3, Inc.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.